Early toxicities associated with a 3-week hypofractionated radiotherapy regimen do not raise initial safety concerns in women ...

Comparison of electron- and proton-based FLASH radiotherapy reveals remarkable similarity in reducing acute skin damage ...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced ATNM-400, a novel, non-PSMA targeting, first in ...

The development of advanced radiotherapy technologies has, in turn, resulted in an increased complexity of operations. Also, a high level of accuracy is needed at every step of the process to achieve ...

Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...

On one side, are over 12,000 men every year in the UK who have their lives cut short by prostate cancer. Families are ...

Mum-of-four Verity Stansfield, 35, was diagnosed with a stage four glioblastoma - the most aggressive type of cancer that ...

Actinium announced ATNM-400, a novel, non-PSMA targeting, first in class radiotherapy for prostate cancer utilizing the Actinium-225 ...

The past and the present merge gently, but not quite imperceptibly, when Karen Shuster speaks about her second son. Morris ...

A CANCER survivor is to be the VIP guest starter for an annual running event which raises funds for life-saving treatment. Donna Crous will launch the “Race for Life”, organised by the Jersey branch ...

Radiotherapy, especially a form known as stereotactic ablative radiotherapy (SABR), is widely used to treat cancers in the ...

• In advanced-stage HL, reduction of chemotherapy or radiotherapy after a negative interim PET scan is probably beneficial for overall survival. • Treatment escalation with rituximab after a positive ...